The Welsh Gender Service pause: what the published record shows

Corrections — 10 October 2026

A check of every page in our coverage against the primary documents, and against each other, found four errors on this page, and two later checks the same day found three more. Each is marked where it occurs, with the original wording kept.

• The panel of 25 September said the health board’s news listing carried nothing after 11 September. It published an update on 25 September.
• The superseded summary of 17 September said both impact assessments list reviewing whether the pause remains necessary and proportionate. Only the equality assessment does.
• The panel of 17 September said we had put three questions for the meeting of 22 September. We put four.
• Our statutory deadlines are now stated subject to the open question about requests signed with a first name only.
• The panel of 5 October counted fifteen questions sent that evening. There were eighteen, in four emails, and seventeen stand.
• The current summary said the review covers people whose surgery was “due”; the terms of reference say “listed”.
• The superseded summary said 450 to 500 patients “are affected”; the Quality Impact Assessment says “potentially affected”.
• Also added on 10 October: a sentence in the current summary that a pause is not a listed Level 3 measure, with the Caswell precedent; notes that the source’s Caswell dates disagree and that the neonatal unit line has not been rechecked; and a note on the leftover secondary-reporting paragraph, which is kept.

The page summary shown in search results and listings still described the version of 1 September and has been replaced. Corrections made on our other pages the same day are listed on our updates page.

Update — 24 and 26 October 2026

24 October. The papers for the sub-committee’s meeting of 30 October include its risk register, which records two new risks for the Welsh Gender Service, opened on 1 September and rated 16 against a target of 8. It lists referral benchmarking against NHS England services as a control in place; no result has been published. The analysis now reads twenty-eight documents.

26 October. Section 2 of the analysis, on who decided and when, is rewritten from the report, the minutes and the Chair’s Action. The final endorsement was given by Chair’s Action on 24 August, after a private session of about an hour. The sub-committee is due to ratify it in public on 30 October.

Update — 23 October 2026: the decision record

The Committee published the papers of the sub-committee’s private session of 24 August with the papers for its meeting of 30 October: the redacted report it considered, the draft minutes, and a Chair’s Action approving the recommendations afterwards. It describes this as going beyond what would ordinarily be published for private business, and that is to its credit.

The route was this. The Senior Leadership Team endorsed the report on 17 August. The sub-committee discussed it in private on 24 August and left its recommendations for approval “offline”. A Chair’s Action, after consultation with the sub-committee’s lay members, then approved them. The Committee’s Medical Director wrote to Cardiff and Vale on 25 August. We hold that letter: it was released to us in answer to CTMUHB_574_26 on 22 October.

The report recommended pausing referrals and surgical assessments, not scheduled surgery. The pause of surgery was added in discussion, after members considered and rejected letting patients with booked dates proceed. The report’s impact assessment screening boxes read “No”; the assessments were to follow. It gives the masculinising genital progression rate as 36%, where the letter of the next day gives 34%, and gives the first figure for feminising genital surgery, 30.1% of cases not progressing, with no English comparator. It describes the complaints as “several” over two years, then three items from 12 August: material gathered by one complainant through freedom of information requests, a complaint to the Deputy First Minister and Cabinet Minister for Social Justice and Equality, and a whistleblowing letter from a medical professional. It gives no count. The letter of 25 August says the pattern “suggests that Welsh patients are being excessively referred for gender affirming surgery without the appropriate assessment”. The Committee now says no case-level review had been completed before the pause.

Also on 23 October, the Committee answered our four letters of 5 and 6 October. It confirmed 34% as the correct figure and said four clinicians will carry out the reviews. It declined to publish the review framework, criteria or any procedure-level analysis while the review is ongoing. Everything is set out on our correspondence page and in the analysis, which now reads twenty-seven documents.

Update — 19 October 2026

The first answer to our freedom of information requests. In a response dated 19 October to our request CTMUHB_569_26, the health board, answering for the Committee, says the report and minutes of the sub-committee meeting of 24 August will be published on 23 October with the papers for its meeting of 30 October. It withholds them until then under section 22. It dates the concerns behind the pause to “routine quality and safety checks in July and August 2026”. It gives their sources as “clinicians, surgeons working in gender surgical services, patients’ families and other correspondence”, which is a fifth description. It says “the higher referral rate was not treated as sufficient evidence on its own”, and that the pause “did not amount to a finding that any individual patient’s referral or planned surgery was inappropriate”. It gives no procedure-by-procedure reason for the scope, and it does not mention the progression rates. It does not say whether any equality assessment preceded 26 August, gives no number of complaints, and does not say whether an escalation letter was issued or who the Executive Lead is. A written response to the ten themes of public questions is promised “shortly”. The full summary is on our correspondence page.

Update — 12 October 2026

Llais was invited to comment on the terms of reference. Answering our letter of 5 October, Llais told us it has now received the terms of reference and was invited to comment on them before they were finalised. It was sent them on 22 September, the day of the Joint Committee meeting, and submitted its comments the next day. It had asked for people’s experiences of the pause to be included in the review, and was told they will be considered as part of the wider review. It said it had asked that the review explicitly consider equality, accessibility and broader patient impacts. It also reported being told the pause will be lifted once the review has concluded and the Committee has sufficient assurances that the pathway is “safe, clinically robust and supported by appropriate governance arrangements”, a third wording of the exit condition, which we record as reported. The full summary is on our correspondence page.

Update — 10 October 2026

A second Welsh Government freedom of information release dates when the Government knew. ATISN 27436 (response dated 28 September, published 6 October) answers a request about a Member of the Senedd’s correspondence on the service. It says the Government “was informed by the NWJCC on 18/08/2026 that concerns were being discussed at the Quality Safety and Outcomes meeting on 24/08/2026”, and that “On 25/08/2026, officials were informed of the outcome of the Committee meeting”. That was the day before the service was placed at Level 3. It repeats that the Government “does not have a role in the NWJCC escalation process”, and withholds its correspondence with NHS Wales on the decision under section 35(1)(a). It is added to our analysis as D19. It changes no finding. An attached ministerial letter of June 2026 says officials meet the Committee monthly; the earlier release, ATISN 27435, in the panel of 9 October below, gave terms of reference for quarterly oversight meetings, and neither says whether these are the same meetings. (Added 10 October 2026.)

A petition. A Senedd petition, “Immediately unfreeze gender-affirming surgeries and protect NHS Welsh Gender Service patients”, had more than 17,900 signatures as at 10 October. It passed the 10,000 signatures at which the Petitions Committee considers a debate on 5 September. It is open until 3 March 2027, and no debate has been scheduled. The petition is not ours. We record it as part of the public record.

Update — 9 October 2026

The Welsh Government has published its answer to a freedom of information request about the pause. The release, ATISN 27435, was published on 6 October; the response is dated 28 September, to a request received on 28 August for documents “relating to oversight of the NHS Wales Joint Commissioning Committee (NWJCC) decision to pause gender-affirming surgery referrals”.

Its account of who decided agrees with the Committee’s. “The escalation of the Wales Gender Services and pause in gender affirming surgery were clinical decisions made by the NHS Wales Joint Commissioning Committee. The Welsh Government does not have a role in this process.” And: “The Welsh Government did not have a role in the pause decision.” Like the Committee’s own statements, it does not say on what paper or at what meeting.

It confirms that ministerial briefings and correspondence exist, and withholds them. For ministerial briefing papers on the pause decision, and for correspondence with the Committee about the pause, the answer is the same: “The Welsh Government does hold information that falls within the scope of your request”, withheld under section 35(1)(a) of the Freedom of Information Act, which protects the formulation of government policy. The annex says the information “relates to Welsh Government policy views on the gender identity services in Wales” and calls the matter “a ‘live’ issue”.

One answer sits uneasily with the Committee’s. Asked for assurance reports the Committee provided, the Welsh Government replied: “All reports relating to the pause of the Welsh Gender service are publicly available on the NHS Wales Joint Commissioning Committee webpages.” Six days earlier the Committee Secretary had said the paper considered in the sub-committee’s private session would be published later, with the minutes; as at 9 October neither has been. The answer may cover only reports the Welsh Government itself received. It does not say.

Two answers are partial. Asked whether legal advice was sought or received on the lawfulness of the pause, the reply is that the decisions were clinical decisions for the Committee; it does not say whether any advice is held. Asked for documents showing its oversight role, the Welsh Government released the April 2025 terms of reference for its quarterly oversight meetings with the Committee; it does not say whether any of those meetings has discussed the pause. (Note added 10 October 2026: a ministerial letter of June 2026, released under ATISN 27436 and recorded in the panel of 10 October above, says officials meet the Committee monthly. Neither document says whether it describes the same meetings as the other, so both are recorded as stated.)

What this does not show. Having no role in the decision is consistent with ministers meeting the Committee on 4 September, as ITV Wales reported (source named 10 October 2026), and seeking assurances afterwards, and we do not suggest otherwise. The response was sent within the statutory time limit. The request was not ours.

And a date has moved. The sub-committee’s next meeting, at which minutes are ordinarily confirmed, has moved from 26 to 30 October. The Committee Secretary said the minutes of 24 August would be published around 21 October.

Update — 6 October 2026

The Committee published the terms of reference on its own website this morning, under Policies and Resources, announcing in a news item that it “has today published the Terms of Reference for the Independent Clinical Review relating to patients referred for gender affirming surgery through the Welsh Gender Service”. That is the commitment as given in the progress update of 23 September and repeated by the health board on 25 September. It is met, a day after we wrote asking where the document would appear, and ten days after the week in which the Chief Commissioner said it would be published.

The same item repeats the Committee’s account of who decided, and when. It states: “On 24 August 2026, NWJCC took the decision to pause referrals for gender affirming surgery from the Welsh Gender Service, assessments by surgical providers and new surgeries.”

Corrected later on 6 October: an earlier version of this panel called this a fourth account and the first time the Committee had said in its own words that it took the decision. It is neither. The sentence appears word for word in the Committee’s progress update of 23 September, which we had already read; we failed to check the new item against it. The sentence does not settle the question. The only body recorded as meeting on 24 August is the Quality, Safety and Outcomes Sub-Committee — which the Committee Secretary said on 22 September “isn’t a for[um] that’s made this decision”, and which the Chief Commissioner’s report describes as endorsing a recommendation rather than taking one. The service was placed in escalation on 26 August, and the review’s first cohort is dated from 26 August in the same news item.

So the Committee now attributes the decision to itself on a date when the only recorded meeting was of a body said not to have decided. The confirmed minutes of 24 August, due around 21 October, remain the document that should show what actually happened.

Corrected, 6 October 2026: the last paragraph overstated the record. At the Joint Committee meeting of 22 September the Chief Commissioner said “We took the decision”, and a Joint Committee lay member said the matter had been scrutinised in a private (“in-committee”) session of the Quality, Safety and Outcomes Committee. We had the recording and missed both. What remains unpublished is the record itself: the paper, the record of the meeting that took the decision, and the advice before it. The Committee Secretary has said the minutes and the paper will be published around 21 October. The paragraph is left as published. Our full reading is in The published record, analysed.

Update — 5 October 2026

On 5 October Cardiff and Vale University Health Board rewrote its Welsh Gender Service FAQs. A new section of twenty-three questions sets out how the Independent Clinical Review will work, and the terms of reference for the review were published the same day.

Correction, 5 October 2026. For part of today this panel said the opposite: that every reference to the terms of reference had been removed from the FAQs, and that the document had not appeared. The references were removed because the document had been published. We reached the wrong conclusion from a deletion without opening the health board’s news listing alongside the page that had changed. Further correction, later on 5 October 2026: that account understated it. The news listing had itself been under automated monitoring since 25 September, but the monitor was fetching the page without running JavaScript and the listing is assembled by JavaScript, so it captured only the navigation and footer. It could not have reported a new item at any point, and it reported no error while failing. We have rebuilt it to render the page in a browser and confirmed it now reads the article list. A monitor that reports no error is not evidence that nothing has changed. A question put to the Committee on that footing has been withdrawn. The entry below has been rewritten; this note records what it said.

What has been published. The review covers three groups: patients whose surgery was due between 26 August and 31 December 2026, who are reviewed first; patients already assessed and waiting for surgery after 31 December; and patients referred but still awaiting a surgical assessment. (Note added 10 October 2026: this panel summarises the health board’s FAQs of 5 October, and we have not rechecked its wording against them since. The terms of reference define the first two groups by when patients are listed for surgery, not by when surgery was due or whether they were assessed; the current summary above uses their wording.) It will be carried out by independent gender clinicians from outside the Welsh Gender Service, who will read clinical records and meet patients. Those in the first group will normally be offered an appointment, usually online, in person if that is not suitable. The reviewers will consider the information available when the referral was made and any change in the patient’s circumstances since. Decisions about care remain with the Welsh Gender Service, which stays responsible for each patient throughout.

This is the most substantial patient-facing information published since the pause began, and it answers questions patients have been asking since August. Two of its answers cut against the way this decision has been characterised publicly. Asked “Does this mean my referral was wrong?”, the health board answers: “No. The purpose of the review is to provide independent assurance and understand whether the referral and assessment processes were appropriate.” It adds that a patient needing further assessment now “does not automatically mean anything was wrong with their original referral.”

And the terms of reference are published. They appeared the same day, on the health board’s own website. Its news statement of 5 October records that “the Terms of Reference for the Independent Clinical Review, led by the NWJCC are now available on our website”. The FAQ question that had asked when they would be published was removed because it had been answered.

Two things about that are worth keeping. The document was published on the health board’s site, where the Committee’s progress update of 23 September and the health board’s own statement of 25 September had both said it would appear on the Committee’s. And it came ten days after the week in which the Chief Commissioner said, on 22 September, that it was agreed or in its final stages and would be published. The commitment was kept late, and kept somewhere other than where it was promised.

We have read the document in full and set out what it says in Clearer safeguards, figures that do not reconcile, and a screening method that needs explaining, rather than characterise it here. In short: it is the most careful thing published in this matter, and it also records masculinising chest surgery — half of all referrals — as progressing at a rate comparable to England without saying what keeps those referrals suspended; gives the masculinising genital progression rate as 34% where the Committee’s own Quality Impact Assessment gives 36% of a differently worded denominator; does not mention feminising genital surgery at all; and proposes a desktop screen on body mass index, smoking and hormone duration without stating how it will preserve the published specification’s own exceptions on each. Ten questions went to the Committee that evening, and five more followed. (Corrected, 10 October 2026: that count left out a third letter of three questions, one of which we withdrew the same evening. In all, eighteen questions went in four emails, and seventeen stand.)

Three smaller changes. The condition for ending the pause is now stated twice, in different terms. The pause lasts until the Committee is “satisfied that the necessary clinical assurance has been received and that appropriate arrangements are in place”. Referrals restart once it is satisfied that assurance has been received “and any identified improvements have been addressed”. The second adds a requirement that was not there before, and nothing has identified those improvements yet, because that is what the review is for.

The commitment on prioritisation is restated in the same words as on 23 September: the Committee “has sought confirmation from NHS England surgical providers that patients who are able to proceed with surgery following review will be prioritised”. Sought, twelve days ago, and still not reported as given.

And the end-of-December target for the first group is now “the current aim”, where on 22 September the Committee said it was confident the work could be done in that period.

One new word. Patients part-way through a planned series of procedures “will not usually need to be reassessed unless a new clinical or safeguarding concern has been identified.” Two other answers still state, without qualification, that the pause does not affect such patients and that existing arrangements for them remain in place. Read narrowly the two address different things, one the pause and the other reassessment, but a patient part-way through a series cannot tell from the FAQs which governs their case. The terms of reference appear to account for the word — safeguarding features in them as a domain a reviewer considers and as a category requiring immediate escalation, rather than as an allegation made about this pathway — and our reading of that document is linked above.

Correction — 25 September 2026

We said we could not find the Committee’s statement on its website. That was wrong. The NHS Wales Joint Commissioning Committee has a news section at jcc.nhs.wales/news/, and both its statement of 4 September and its progress update of 23 September have been published there since the day each was issued. We searched the site, did not find the section, and told readers the Committee appears not to publish its statements. We should have found it. The error is ours.

Three things follow from reading both.

The 4 September statement names masculinising genital surgery specifically as the category where a significantly lower proportion of Welsh patients progressed to surgery following referral. At the meeting on 22 September the dropout rate was presented to the Committee as a feature of the pathway, without that category being named.

It describes the concerns more fully than anything published since: whether aspects of the assessment process before referral had been completed appropriately, including whether some patients met the basic requirements for surgery such as body mass index and overall surgical fitness, and whether wider health needs had been fully considered. The source is given as information from clinicians and correspondence received — a fourth description, after “members of the public”, “some patients” and “families of people going through this”.

And it says the Quality, Safety and Outcomes Committee considered the information and concluded that the service should move to Level 3 escalation, with the pause and review to follow. At the meeting on 22 September the Committee Secretary said that body “isn’t a for[um] that’s made this decision”. Both are the Committee’s own words.

The 23 September update confirms, from a primary source, what we had recorded from press reporting: the apology, the wider review scope, and the sequence in which the terms of reference will be published. It also states that individual patients will have surgery reinstated as soon as their own review is complete, without waiting until December.

Update — 25 September 2026

At the Joint Committee meeting on 22 September the Chief Commissioner said the terms of reference for the independent clinical review were agreed or in the final stages of agreement and would be published later that week. The Committee’s update of 23 September indicated instead that affected patients would be contacted once review arrangements were finalised, and that the terms of reference would then be published. As at today they have not appeared on the Committee’s website or the health board’s. We have asked when and where they will be published.

On 25 September the Committee referred our follow-up of 23 September to Cwm Taf Morgannwg University Health Board, which handles information requests on its behalf, where it has been registered as a request under the Freedom of Information Act. We had asked for it to be treated as correspondence in the first instance. Since the eleven questions we put on 1 September remain unanswered after twenty-four days, we have resubmitted those under the Act as well. Both requests now carry a statutory deadline of twenty working days, and a right of internal review and referral to the Information Commissioner that correspondence did not.

Corrected, 10 October 2026: these deadlines and rights should have been stated subject to one question. The Freedom of Information Act requires a request to state the applicant’s name, which the Information Commissioner’s guidance reads as their real name, and our requests are signed with the author’s legal first name without a surname, so their validity is open. (Amended later on 10 October: this note first said we publish under “a name that is not a legal name”, which was wrong.) It is set out on our correspondence page.

The health board’s Welsh Gender Service FAQs were revised on 23 September. The section on where patients can find further information now states that the Joint Committee is “currently finalising the Terms of Reference for the Independent Review”, and adds: “We apologise sincerely for the upset this has caused to both individual patients and their families and people in the broader Trans community.” The apology is unreserved and to the health board’s credit. The same text confirms that as at 23 September the terms of reference were still being finalised, the day after the Committee was told they were agreed or in the final stages and would be published later that week. No accompanying statement was published: the health board’s news listing carries nothing on the Welsh Gender Service after 11 September, and the change was made by revising the FAQ page.

Corrected, 10 October 2026: that was wrong. The health board published a Welsh Gender Service update on 25 September, and we missed it. The paragraph is left as published.

The Pembrokeshire Herald reported on 23 September that the Committee had issued an update that day. We have been unable to locate it on the Committee’s website and have asked where the Committee publishes its public statements. According to that reporting the Committee apologised for the distress caused; said this remains a pause and not a permanent change to the service; confirmed that patients awaiting surgery in 2027 and those awaiting a surgical assessment will also have their referrals reviewed, a wider scope than previously described; said confirmation had been sought from NHS England providers that patients cleared by the review would be prioritised; and said no decisions about individual patients’ care had yet been made. The wider scope is to the Committee’s credit. We record it from secondary reporting and will replace this with the primary text if it becomes available.

Note, 10 October 2026: the primary text is the Committee’s own update of 23 September on its news page, recorded in the panel of 25 September above. This paragraph is kept because this page removes nothing.

The meeting of 22 September is covered separately in What the Joint Committee said, and what it did not.

Welsh Gender Service — our coverage

1. Our position — what was decided, what has not been shown, and what we ask
2. What the published record shows — the running record, updated as the position changes, with full revision history (you are here)
3. The papers justifying the gender surgery pause do not hold up — the two impact assessments published on 17 September
4. What the Joint Committee said, and what it did not — the meeting of 22 September, with a timestamp index to the recording
5. The pause may be right. The process cannot show it — where this stands, stated as a view
6. The terms of reference, read in full — what the governing document settles, and what it leaves open
7. The published record, analysed — twenty-eight documents read against each other (seventeen at publication, eleven added since), every finding graded and independently checked
8. Where the record stands — our view after the terms of reference, and eight things we ask
9. What the decision record shows — our view after the papers of 24 August were published
10. Our correspondence — every approach to a public body, what was asked, and where each stands
11. Commitments made — what these bodies have promised, and whether it has been kept

Update — 17 September 2026

The NHS Wales Joint Commissioning Committee published the papers for its meeting of 22 September. They contain a great deal that was not previously on the record, and several statements in this piece are superseded as a result. The summary at the top of the page has been revised; the changes are set out here.

An equality impact assessment now exists. This piece previously said the published record contained none. That was accurate when written and is no longer. An Equality and Welsh Language Impact Assessment and a Quality Impact Assessment are appended to the papers as items 2.3.2 and 2.3.1. The equality assessment runs to sixteen pages, addresses the public sector equality duty explicitly, and concludes that the overall equality impact of the pause is negative, with gender reassignment the characteristic most directly affected. It is a more substantial document than we anticipated. It is also appended to a meeting on 22 September, and the pause took effect on 26 August.

The dates were not as reported. This piece followed the health board’s statement of 28 August in saying the decision was taken on 24 August when the service was escalated. The Chief Commissioner’s report records that the Sub-Committee endorsed the recommendation and the pause proposals on 24 August, and that the service “was placed in escalation, level 3 on August 26th, 2026.” Two dates, not one.

A recommendation was before the Sub-Committee. This piece noted that the Director of Commissioning’s report to the 24 August meeting recommended only that members take assurance and proposed no pause. That remains true of that paper. But the Chief Commissioner’s report makes clear that a separate recommendation to escalate, and separate proposals to pause assessments and surgery, were also before the Sub-Committee and were endorsed. The decision paper itself has not been published.

The referral data is published. 403 referrals from the Welsh Gender Service in 2025-26 against a population of 3,186,600, or 12.6 per 100,000, compared with 1,803 from English services against 58,620,100, or 3.1 per 100,000. Broken down by surgery type: masculinising chest 201 referrals at 6.3 per 100,000 against 1.5; feminising genital 149 at 4.7 against 1.0; masculinising genital 53 at 1.7 against 0.6. The source is NHS England’s Gender Dysphoria National Referral Support Service, so the denominator is consistent on both sides.

And the progression figures are published for the first time. The Quality Impact Assessment records that 97% of patients listed for masculinising chest surgery proceed to surgery, against 36% for masculinising genital surgery. The low-progression limb of the public justification therefore rests on the smallest of the three categories. The assessment describes that figure as “an outlier requiring further investigation” which “should not, at this stage, be treated as proof that patients have been referred inappropriately.”

Other facts from the papers. Around 450 to 500 patients are affected overall (corrected, 10 October 2026: the Quality Impact Assessment says “potentially affected”), of whom about 100 have a surgical date this year and approximately 60 were due surgery between August and the end of December. Panel appointments for the urgent clinical review have been made, with terms of reference anticipated for approval and work expected to begin in the week commencing 21 September. Existing waits on some of these surgical pathways run to approximately eight years.

How other escalations were handled. The papers document three other Level 3 escalations by this commissioner. Salford Royal bariatric surgery, January 2025: the Commissioning Team recommended, the Senior Leadership Team endorsed on 8 January, and a letter went to the provider’s chief executive requesting an executive lead. Caswell Clinic, October 2025: endorsed by the Senior Leadership Team, letter to the health board executive team, weekly improvement meetings established. The South Wales Specialist Auditory Implant Device Service, October 2025: endorsed by the Senior Leadership Team, formal escalation letter issued on 6 October, with the subsequent delay in confirming an executive lead recorded as a problem. Three escalations, one route, a letter each time. For the Welsh Gender Service the endorsement is recorded as coming from the Sub-Committee, and no escalation letter, executive lead or paper to the Corporate Directors Group appears anywhere in the published papers. (Updated 20 October 2026: a freedom of information response of that date says a formal escalation letter was issued on 26 August, after verbal notification on 24 August. It has not been published. Updated 23 October 2026: the letter, released to us on 22 October, is dated 25 August, and the report was endorsed by the Senior Leadership Team on 17 August, as in the other cases.)

A precedent that cuts against us. This piece cited the neonatal unit and Salford bariatric surgery as Level 3 services that were not suspended. The escalation trajectories appendix published on 17 September records a closer comparator that we had not seen. Caswell Clinic, at Level 3, had admissions suspended in September 2025 “pending assurance that immediate safety risks had been addressed”, reopening in January 2026. So this commissioner has suspended part of a service at Level 3 before. (Note, 10 October 2026: the source’s own dates for Caswell do not agree. The same papers give its escalation as October 2025 and the suspension of admissions as September 2025.) Two differences remain, and we think they matter: Caswell’s suspension stopped new admissions rather than cancelling treatment already scheduled for identified patients; and it followed a site visit in July 2025 at which NWJCC representatives observed safety concerns directly, and a full service review including patient-level review. Here the trigger was referral data which the commissioner’s own Quality Impact Assessment says should be treated as a signal requiring investigation rather than proof.

We have put three questions to the Committee for its meeting on 22 September and will publish the answers, or record their absence.

Corrected, 10 October 2026: we put four questions, not three, as the letter itself and every other page record.

Correction — 8 September 2026

The update below, published on 7 September, stated that Llais had been given an outline of the independent review’s proposed scope. That was wrong, and we are grateful to Llais for correcting it.

Llais has since checked its records and confirmed that the commissioner did not share the scope of this review with it at all. The earlier answer had conflated this review with others for which scope had been shared. Llais holds nothing on the scope of this review.

The commissioner has told Llais that it has developed an initial indicative scope, but that this will need to be further shaped and refined with support from the expert review team to ensure the process is thorough and robust.

The error originated in information given to us in good faith and corrected promptly and unprompted. It appeared in something we published, so it is corrected here on the same terms as any other error. The original wording is marked below rather than removed.

Update — 7 September 2026

Llais, the statutory body representing people who use NHS Wales services, issued a statement on 3 September and has since answered questions we put to it directly. Together these add several facts not previously reported, including two that narrow the effect of the pause.

The pause does not affect people progressing through a planned series of surgical procedures as part of a transition pathway, people who require treatment for complications, or people who have already begun a series of gender-affirming surgeries and need clinically necessary aftercare. When the service resumes, people will be considered in the order they held on the surgery waiting list. Both points came from the commissioner via Llais and neither appears in the original announcement.

On the governance question, Llais said it first became aware of the change when it was publicly announced, that it did not see the information that led to the decision before it was taken, and that it would have expected earlier engagement as the independent body representing people who use NHS Wales services. In answer to our questions, Llais confirmed it was formally notified on 1 September, four days after the public announcement and eight days after the decision, and that it had no role in the decision-making process. It also confirmed that it has not received the terms of reference for the independent review, and has been given only an outline of the proposed scope.

[Corrected, 8 September 2026. The final clause was wrong. Llais has since confirmed that the commissioner did not share the scope of this review with it at all, and that the earlier answer conflated this review with others. See the correction above.]

Two qualifications belong with that. Being formally notified on 1 September is not the same as being unaware until then, and Llais’s own statement makes clear it knew from the announcement. And patient-voice bodies are not ordinarily consulted on urgent clinical safety decisions; Llais represents rather than decides. The point is narrower: the commissioner’s own framework treats involvement of the citizen voice body as critical at the level at which service delivery is stopped, and the measure was applied a level below that.

The commissioner told Llais on 3 September that it is working to put in place the patient safety, quality assurance and clinical governance arrangements needed to resume the service as soon as possible. The Welsh Government said the following day that each relevant case will be reviewed. Those are not the same remedy, and it is not yet clear whether both are intended.

Llais is asking people whose care has been affected to share their experience, through its national survey or its local teams.

Update — 5 September 2026

On 4 September, after meeting the health minister and the deputy first minister, the NHS Wales Joint Commissioning Committee set out its reasoning publicly for the first time. (Note added 10 October 2026: the source for that meeting is press reporting. ITV Wales reported that the Health Minister, the Social Justice Minister and the Deputy First Minister met the Committee that day. The panel is left as published.) This piece was published on 1 September, and parts of it are superseded.

The committee said that the proportion of Welsh patients progressing from referral to surgery, for some types of surgery, was significantly lower than in England; that in some cases patients did not meet the basic requirements for surgery, with body mass index arising as a factor; that there were concerns about whether wider health needs had been fully considered; and that some clinical professionals had raised concerns about whether parts of the referral assessment process had been carried out appropriately.

That is the specific concern this piece said the published record did not contain. It now does. It is also a more coherent account than the referral rate on its own: referrals made for patients who do not meet the surgical provider’s criteria would produce both a higher referral rate and a lower progression rate, from a single cause. Two figures, one explanation.

The Welsh Government said ministers sought and received assurances that the decision is a pause rather than a stop, that each relevant case will be reviewed, and that individuals will progress to surgery once the committee has assurances that appropriate clinical assessments are in place. Case-by-case review is what this piece said was the only thing capable of answering the question.

What this piece said about the governance record stands. The decision itself, the authority under which it was taken, and any equality impact assessment are still absent from the published record, and the measure taken still corresponds to a level of the committee’s own escalation framework above the one applied. A decision can be substantively right and still be taken without a recorded basis. Those are separate questions and only the second is still open.

Affected passages are marked in the text above. Nothing has been deleted.